CT News and Research

RSS

Sheffield breast cancer patient takes part in new drug research trial

A SHEFFIELD patient has become the first in the world to take part in a new drug research trial aiming to better control secondary breast cancer, or cancer which has spread to other parts of the body including the bones, liver and lungs for longer.

12 Jan 2015

NCCN collaborates with Flatiron Health to create oncology outcomes database

The National Comprehensive Cancer Network is collaborating with Flatiron Health to create a cloud-based data repository of NCCN Member Institution data - the NCCN Outcomes Database.

9 Jan 2015

Improving headache treatment could reduce health care spending, new study suggests

Each year more than 12 million Americans visit their doctors complaining of headaches, which result in lost productivity and costs of upward of $31 billion annually. A new study by researchers from Beth Israel Deaconess Medical Center suggests some of that cost could be offset by physicians ordering fewer tests and an increased focus on counseling about lifestyle changes.

8 Jan 2015

Saatchi Bill: an interview with Dr. David Collingridge, Editor-in-Chief, The Lancet Oncology

The intention of the Medical Innovation Bill is to encourage and support doctors to explore new medicines for their patients when they believe existing options are no longer achieving good outcomes.

4 Jan 2015

Study shows that reprogramming stem cells can prevent cancer following full body radiation

The body has evolved ways to get rid of faulty stem cells. A University of Colorado Cancer Center study published today in the journal Stem Cells shows that one of these ways is a "program" that makes stem cells damaged by radiation differentiate into other cells that can no longer survive forever.

31 Dec 2014

IMRIS closes private placement offering of 10,563,380 units

IMRIS Inc. today announced it has closed the private placement offering of 10,563,380 units at an offering price of US$0.284 per unit.

25 Dec 2014

Comprehensive care improves health of high-risk, chronically ill children, reduces hospital costs

High-risk children with chronic illness who received care at a clinic that provided both primary and specialty care and features to promote prompt effective care had an increase in access to care and parent satisfaction and a reduction in serious illnesses and costs, according to a study in the December 24/31 issue of JAMA.

24 Dec 2014

Research shows modern humans have less bone density than earlier human ancestors

New research shows that modern human skeletons evolved into their lightly built form only relatively recently — after the start of the Holocene about 12,000 years ago, and even more recently in some human populations.

23 Dec 2014

Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Penumbra, Inc., the market leader in intra-arterial stroke treatment, announced that an independent study published online today in the New England Journal of Medicine found that intra-arterial stroke treatment, including the company's clot extraction technology, was shown to be significantly more effective than medical management with tissue plasminogen activator (tPA), which is the current standard of care.

18 Dec 2014

Researchers find new 'sliding scale' model to rule out blood clots in lungs

Researchers from Intermountain Medical Center in Salt Lake City have identified a new "sliding scale" model used to rule out potentially deadly blood clots in the lungs, known as pulmonary embolisms, that is more accurate than current diagnostic methods.

17 Dec 2014

Lung cancer in women: an interview with Harold Wimmer and Chuck Brynelsen

We at the American Lung Association know that lung cancer is the number one cancer killer among women, however, there is a startling lack of information available to the public regarding lung cancer.

16 Dec 2014

Apheresis: A potent therapeutic in extracorporeal photopherisis

Apheresis, the simple process of drawing blood, becomes a powerful therapeutic in extracorporeal photopherisis (ECP) according to clinicians and scientists who met at the NIH State of the Science Symposium in Therapeutic Apheresis. Nora Ratcliffe, MD, of Dartmouth Hitchcock, looked at current methodology and opportunities for research in a paper recently published in Transfusion Medicine Review, titled "National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis."

14 Dec 2014

Midazolam drug helps recover full consciousness in traumatic brain injury patient

A patient who had suffered a traumatic brain injury unexpectedly recovered full consciousness after the administration of midazolam, a mild depressant drug of the GABA A agonists family.

14 Dec 2014

New study compares usefulness of two biomarkers released into the blood after TBI

In cases of traumatic brain injury (TBI), predicting the likelihood of a cranial lesion and determining the need for head computed tomography (CT) can be aided by measuring markers of bone injury in the blood.

14 Dec 2014

$Using Refractory Metals in Cancer Treatments$

Using Refractory Metals in Cancer Treatments

This interview discusses how refractory metals can be used in cancer treatments.

From H.C. Starck Solutions 10 Dec 2014

New technique shows promise for early diagnosis of cardiovascular disease

A new technique developed at Sweden's KTH Royal Institute of Technology shows promise for early diagnosis and treatment of cardiovascular disease.

9 Dec 2014

MorphoSys, Xencor announce final results from MOR208 Phase 1/2a trial in patients with CLL/SLL

MorphoSys AG and Xencor Inc. today announced the publication of final results of a Phase 1/2a trial evaluating MOR208 (formerly XmAb5574) in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL).

7 Dec 2014

Two medical imaging techniques could predict effectiveness of TB drugs

Two medical imaging techniques, called positron emission tomography (PET) and computed tomography (CT), could be used in combination as a biomarker to predict the effectiveness of antibiotic drug regimens being tested to treat tuberculosis (TB) patients, according to researchers at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

5 Dec 2014

Study: PET scanning strategy could help predict effectiveness of TB drugs

Sophisticated lung imaging can show whether or not a treatment drug is able to clear tuberculosis (TB) lung infection in human and macaque studies, according to researchers at the University of Pittsburgh School of Medicine and their international collaborators.

5 Dec 2014

SurgiQuest receives Most Promising Life Sciences Company of the Year award

SurgiQuest was awarded "Most Promising Life Sciences Company of the Year" due to its potential for growth, success and impact on the Life Sciences market in Connecticut. The company's flagship product, the AirSeal System, improves patient outcomes, enhances perioperative efficiency, reduces costs and increases hospital profitability.

4 Dec 2014

CT News and Research

Sheffield breast cancer patient takes part in new drug research trial

NCCN collaborates with Flatiron Health to create oncology outcomes database

Improving headache treatment could reduce health care spending, new study suggests

Saatchi Bill: an interview with Dr. David Collingridge, Editor-in-Chief, The Lancet Oncology

Study shows that reprogramming stem cells can prevent cancer following full body radiation

IMRIS closes private placement offering of 10,563,380 units

Comprehensive care improves health of high-risk, chronically ill children, reduces hospital costs

Research shows modern humans have less bone density than earlier human ancestors

Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Researchers find new 'sliding scale' model to rule out blood clots in lungs

Lung cancer in women: an interview with Harold Wimmer and Chuck Brynelsen

Apheresis: A potent therapeutic in extracorporeal photopherisis

Midazolam drug helps recover full consciousness in traumatic brain injury patient

New study compares usefulness of two biomarkers released into the blood after TBI

Using Refractory Metals in Cancer Treatments

New technique shows promise for early diagnosis of cardiovascular disease

MorphoSys, Xencor announce final results from MOR208 Phase 1/2a trial in patients with CLL/SLL

Two medical imaging techniques could predict effectiveness of TB drugs

Study: PET scanning strategy could help predict effectiveness of TB drugs

SurgiQuest receives Most Promising Life Sciences Company of the Year award

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News